ALGN
Price
$211.03
Change
-$2.55 (-1.19%)
Updated
Dec 20, 04:59 PM (EDT)
38 days until earnings call
UTMD
Price
$61.04
Change
-$1.04 (-1.68%)
Updated
Dec 20, 04:59 PM (EDT)
39 days until earnings call
Ad is loading...

ALGN vs UTMD

Header iconALGN vs UTMD Comparison
Open Charts ALGN vs UTMDBanner chart's image
Align Technology
Price$211.03
Change-$2.55 (-1.19%)
Volume$29.15K
CapitalizationN/A
Utah Medical Products
Price$61.04
Change-$1.04 (-1.68%)
Volume$405
CapitalizationN/A
ALGN vs UTMD Comparison Chart
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. UTMD commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and UTMD is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ALGN: $211.06 vs. UTMD: $61.02)
Brand notoriety: ALGN: Notable vs. UTMD: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALGN: 172% vs. UTMD: 218%
Market capitalization -- ALGN: $24.63B vs. UTMD: $255.21M
ALGN [@Medical Specialties] is valued at $24.63B. UTMD’s [@Medical Specialties] market capitalization is $255.21M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileUTMD’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • UTMD’s FA Score: 1 green, 4 red.
According to our system of comparison, UTMD is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 6 TA indicator(s) are bullish while UTMD’s TA Score has 4 bullish TA indicator(s).

  • ALGN’s TA Score: 6 bullish, 4 bearish.
  • UTMD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALGN is a better buy in the short-term than UTMD.

Price Growth

ALGN (@Medical Specialties) experienced а -10.34% price change this week, while UTMD (@Medical Specialties) price change was -2.53% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

ALGN is expected to report earnings on Jan 29, 2025.

UTMD is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($24.6B) has a higher market cap than UTMD($255M). ALGN has higher P/E ratio than UTMD: ALGN (55.01) vs UTMD (15.45). ALGN YTD gains are higher at: -22.971 vs. UTMD (-26.229). ALGN has higher annual earnings (EBITDA): 799M vs. UTMD (23.1M). ALGN has more cash in the bank: 973M vs. UTMD (92.9M). UTMD has less debt than ALGN: UTMD (295K) vs ALGN (127M). ALGN has higher revenues than UTMD: ALGN (3.86B) vs UTMD (50.2M).
ALGNUTMDALGN / UTMD
Capitalization24.6B255M9,647%
EBITDA799M23.1M3,459%
Gain YTD-22.971-26.22988%
P/E Ratio55.0115.45356%
Revenue3.86B50.2M7,693%
Total Cash973M92.9M1,047%
Total Debt127M295K43,051%
FUNDAMENTALS RATINGS
ALGN vs UTMD: Fundamental Ratings
ALGN
UTMD
OUTLOOK RATING
1..100
6261
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6461
PRICE GROWTH RATING
1..100
6375
P/E GROWTH RATING
1..100
8875
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTMD's Valuation (13) in the Medical Specialties industry is somewhat better than the same rating for ALGN (75). This means that UTMD’s stock grew somewhat faster than ALGN’s over the last 12 months.

UTMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ALGN (100). This means that UTMD’s stock grew similarly to ALGN’s over the last 12 months.

UTMD's SMR Rating (61) in the Medical Specialties industry is in the same range as ALGN (64). This means that UTMD’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's Price Growth Rating (63) in the Medical Specialties industry is in the same range as UTMD (75). This means that ALGN’s stock grew similarly to UTMD’s over the last 12 months.

UTMD's P/E Growth Rating (75) in the Medical Specialties industry is in the same range as ALGN (88). This means that UTMD’s stock grew similarly to ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNUTMD
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
63%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
57%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
49%
Advances
ODDS (%)
Bullish Trend 14 days ago
75%
Bullish Trend 12 days ago
57%
Declines
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 5 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
55%
View a ticker or compare two or three
Ad is loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTLP9.580.27
+2.90%
Cantaloupe
FHB25.480.28
+1.11%
First Hawaiian
NBIX135.420.46
+0.34%
Neurocrine Biosciences
AQB0.52-0.01
-1.21%
AquaBounty Technologies
CRBP13.00-0.33
-2.48%
Corbus Pharmaceuticals Holdings

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with NVST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-1.18%
NVST - ALGN
52%
Loosely correlated
+3.72%
SAUHY - ALGN
49%
Loosely correlated
+1.91%
STAA - ALGN
48%
Loosely correlated
-0.64%
UTMD - ALGN
44%
Loosely correlated
-1.71%
IDXX - ALGN
44%
Loosely correlated
+0.79%
More

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with ALGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
-1.71%
ALGN - UTMD
45%
Loosely correlated
-1.18%
ICUI - UTMD
41%
Loosely correlated
+2.36%
VCYT - UTMD
40%
Loosely correlated
+4.66%
SIBN - UTMD
39%
Loosely correlated
+1.53%
HBIO - UTMD
39%
Loosely correlated
+0.48%
More